Alice Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 04-07-2024
- Company Age 18 Year, 18 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.43 M
as on 04-07-2024
- Satisfied Charges ₹ 8.39 Cr
as on 04-07-2024
- Revenue 14.71%
(FY 2023)
- Profit -10.67%
(FY 2023)
- Ebitda -35.05%
(FY 2023)
- Net Worth 16.05%
(FY 2023)
- Total Assets 16.97%
(FY 2023)
About Alice Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹6.43 M. The company has closed loans amounting to ₹8.39 Cr, as per Ministry of Corporate Affairs (MCA) records.
Leena Fernandes, Alex Fernandes, Anil Vyas, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MP2006PTC019099
- Company No.
019099
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Alice Pharma Private Limited offer?
Alice Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Dicyclomine Hydrochloride Medicine, Dicyclomine Paracetamol Tablets, Pharmaceutical Medicine, Pharmaceutical Products, Infusion Syringes & Supplies, Syringes, Antibiotic Tablets, Capsule & Syrup, Antifungal Injection, Tablet & Syrup.
Who are the key members and board of directors at Alice Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Vyas  | Director | 25-Nov-2010 | Current |
| Leena Fernandes | Director | 05-Dec-2006 | Current |
| Alex Fernandes | Director | 25-Nov-2010 | Current |
| Neelam Vyas | Director | 05-Dec-2006 | Current |
Financial Performance of Alice Pharma.
Alice Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.71% increase. The company also saw a substantial fall in profitability, with a 10.67% decrease in profit. The company's net worth Soared by an impressive increase of 16.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alice Pharma?
In 2023, Alice Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Myra Healthcare Private LimitedActive 4 years 11 monthsLeena Fernandes and Alex Fernandes are mutual person
Alice Pharma (Mumbai) Private LimitedActive 15 years 8 monthsLeena Fernandes and Neelam Vyas are mutual person
Futura Healthcare & Remedies Private LimitedActive 4 years 11 monthsLeena Fernandes and Alex Fernandes are mutual person
- Shamal Healthcare Private LimitedActive 5 years 1 month
Leena Fernandes and Alex Fernandes are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 31 Aug 2022 | ₹6.43 M | Open |
Others Creation Date: 27 Dec 2017 | ₹1.95 Cr | Satisfied |
Others Creation Date: 19 Jan 2015 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Alice Pharma?
Unlock and access historical data on people associated with Alice Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alice Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alice Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
